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Transplantation between genetically disparate individuals requires chemother- 
apeutic agents to suppress the rejection reaction. Although these agents are vital 
to the suppression of graft rejection, they have their own deleterious side effects 
caused by both nonspecific immunosuppression and drug toxicities. In addition, 
chronic rejection in varying degrees of severity often occurs despite the use of 
these agents. 
Since Medawar and colleagues (1) reported the induction of specific transplan- 
tation tolerance in mice by neonatal injection of allogeneic bone marrow cells, 
the  search  for  methods  to  induce  specific  tolerance  in  adult  recipients  has 
continued  (2-5).  We  have  recently shown  (6)  that  reconstitution  of lethally 
irradiated B 10 mice with T  cell-depleted syngeneic (B 10) plus xenogeneic (F344 
rat) bone marrow results in long-term survival of animals without apparent graft 
vs. host or wasting disease and leads to specific prolongation of donor-type, full- 
thickness tail skin grafts. Such animals promptly rejected third party allogeneic 
and xenogeneic skin  grafts with a  time course similar to that  of unirradiated 
control animals. 
Our  hypothesis for explaining these preliminary results  was that  syngeneic 
components  offered  immunocompetence, while  xenogeneic  elements  led  to 
hyporeactivity across a species barrier. However, neither the extent or specificity 
of this phenomenon as assessed by in vivo and in vitro parameters nor the nature 
of T  cell responsiveness had been characterized in these animals. In this paper, 
we present data detailing the extent and specificity of hyporeactivity achieved 
across a species barrier. Mixed reconstituted animals are shown to exhibit specific 
hyporeactivity to donor antigens as assessed  by skin  grafting and by  in  vitro 
assays, including mixed lymphocyte  culture proliferative and cellular cytotoxicity. 
These animals were immunocompetent, as evidenced by rejection of third party 
mouse and rat skin grafts and development of anti-sheep red blood cell plaque- 
forming responses equivalent to those of syngeneic controls. This new approach 
offers a model for investigation of mechanisms of self-recognition and induction 
and maintenance of transplantation tolerance across species barriers. 
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Materials and Methods 
Animals.  6-8-wk-old male C57BL/10Sn (B10), B10.BR, and B10.D2 mice were pur- 
chased from The Jackson Laboratory, Bar Harbor, ME.  4-8-wk-old Fischer 344 (F344) 
and  Wistar-Furth  (WF)  male  rats  were  purchased  from  the  Charles  River  Breeding 
Laboratories, Inc.,  Wilmington,  MA.  Animals were housed  in a  specific pathogen-free 
facility at the National Institutes of Health (NIH), Bethesda, MD. 
Mixed Xenogeneic Reconstitutions: (B IO + F344 --~ B IO).  Mixed xenogeneically reconsti- 
tuted animals were prepared by a  modification of the method previously described for 
preparation of allogeneic chimeras (7). Briefly, inbred C57BL/10Sn male recipients were 
lethally  irradiated  with  a  single dose of 950  rad  from a  cesium  source.  Using  sterile 
technique,  the  bone  marrow was flushed  with  Media  199  (Gibco Laboratories, Grand 
Island, NY) containing 50 ttg/ml gentamicin (minimum essential medium [MEM]) l from 
the femurs and tibias of C57BL/10Sn male mice and F344 male donors with a 23-gauge 
needle. The marrow was mechanically resuspended in MEM by gentle aspiration through 
a  19-gauge needle and the suspension was sterilely filtered through nylon mesh. The cells 
were then  pelleted at  1,200  rpm for  10  min, resuspended,  and counted.  Marrow cells 
were T cell depleted by treatment with a 1:60 dilution in MEM of rabbit anti-mouse brain 
(RaMB) (1  x  10 a cells/mi of RaMB) at 4°C for 30 min (7). The cells were subsequently 
washed and resuspended in sterile filtered guinea pig complement (Gibco Laboratories) 
at a  1:3 dilution in MEM (1  ×  108 cells/ml) at 37°C for 30 min. Cells were then washed 
twice and resuspended in MEM at the appropriate concentration to allow injection of 1 
ml per animal. Recipient animals were reconstituted within 4-6 h of lethal irradiation via 
the lateral tail veins using a 27-gauge needle. Mixed xenogeneically reconstituted animals 
received  5  x  106  T  cell-depleted  bone marrow cells  and  4.0  x  107  F344  T  cell-de- 
pleted rat bone marrow cells unless otherwise specified. Such animals will be referred to 
as mixed xenogeneically reconstituted mice or B10 +  F344 ~  B10. Fully xenogeneically 
reconstituted animals received 4.0  x  107 T  cell-depleted  F344  rat bone marrow cells. 
Radiation controls were prepared simultaneously to confirm adequacy of the radiation. 
Fully Allogeneic Reconstitutions: (BIO.D2 ~  BIO).  Fully allogeneic chimeras were pre- 
pared using a technique identical to the mixed xenogeneically reconstituted animals. B 10 
recipients were reconstituted with 1.5 x  l0 T T  cell-depleted B10.D2 bone marrow cells. 
Assays for Chimerism.  Chinaerism of peripheral blood lymphocytes was assayed using a 
trypan blue exclusion microcytotoxicity test to determine the percentage of lymphocytes 
bearing donor or host-type H-2 or Rt 1 surface markers as previously described (8). Briefly, 
peripheral blood was collected into heparinized plastic tubes. After thorough mixing, the 
suspension  was  diluted  with  100  #1  of saline  and  layered  over a  cold  FicolI-Hypaque 
gradient (Bionetics Laboratory Products, Kensington, MD). Following centrifugation for 
30 s in a  microfuge (Beckman Instruments, Inc., Fullerton,  CA),  the lymphocyte layer 
was aspirated from the saline-Ficoll interface and washed with MEM plus 0.1%  gelatin. 
Cells were then used in the standard trypan blue microcytotoxicity assay (8). 
Chimerism of spleen,  lymph node,  peripheral blood,  bone marrow, and thymus was 
further assayed using a fluorescence-activated cell sorter (FACS II; B-D FACS Systems, 
Becton,  Dickinson  &  Co.,  Sunnyvale,  CA)  as previously described  (9).  Mouse anti-rat 
antiserum and a fluorescein isothiocyanate-conjugated goat F(ab')2 anti-mouse IgG prep- 
aration (FITC-GAMIgG) (Cappel Laboratories, Cochranville, PA) were used for staining. 
Skin  Grafting.  Skin  grafting  was  performed  by  a  modification  of the  method  of 
Billingham (10).  Full-thickness skin grafts were harvested from the tails of F344  (Rtl a) 
and WF (Rt 1") rats and C57BL/10Sn (H-2  b) and B10.D2 (H-2  d) mice. Mice were anesthe- 
tized  with  tribromoethanol  administered  intraperitoneally  (11)  and  full-thickness graft 
beds were created surgically in the lateral thoracic wall with care taken to preserve the 
panniculus carnosum. The grafts were covered by a double layer of vaseline gauze and a 
I Abbreviations used in this paper:  CM L, cell-mediated lympholysis;  Con A, concanavalin A; FACS, 
fluorescence-activated cell sorter;  FITC-GAMIgG, fluorescein isothiocyanate-conjugated goat anti- 
mouse IgG; FMF, flow microfluorometry;  MEM, minimum essential medium; MLR, mixed lympho- 
cyte reaction; PFC, plaque-forming cell; PHA, phytohemagglutinin; RaMB, rabbit anti-mouse brain; 
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plaster cast to prevent shearing.  If more than one skin graft was placed on an animal, 
each defect for graft placement was separated by a 3-ram or larger skin bridge. Casts were 
removed on the eighth day. Grafts were scored daily for percent rejection, and rejection 
was considered complete when no residual viable graft could be seen. Graft survivals were 
calculated by the life-table method and the median survival time (MST) was derived from 
the time point at which 50% of grafts were surviving. 
Splenectomy.  Partial  splenectomy  was  performed  under  ether  general  anesthesia 
through a left subcostal oblique incision. The vessels supplying the segment of spleen to 
be harvested were crushed with a mosquito snap as they emanated from the splenic hilum 
and the distal segment of spleen was amputated with iris scissors.  A two-layer closure with 
3-0 silk was performed. 
Mixed Lymphocyte Reactions.  Mixed lymphocyte reactions (MLR) were performed as 
previously described (12). Briefly, routine and rat splenocytes were ACK-lysed (ammonium 
chloride potassium carbonate lysing buffer) (NIH Media Unit), washed, and reconstituted 
in EHAA (12) (NIH Media Unit) supplemented with 0.75% normal mouse serum, 0.09 
mM  nonessential  amino  acids,  1  mM  sodium  pyruvate,  2  mM  glutamine,  100  U/ml 
penicillin,  100 #g/ml streptomycin, and 0.05 mM 2-mercaptoethanol. Either 2 X 105 or 
4  x  105 responders were stimulated with 4  ×  105 stimulators (2,000  rad) and varying 
numbers of co-cultured putative suppressors or control normal cells in a total of 200 or 
250 ul of media. Cultures were incubated at 37 °C in 5% CO~ for 4 d, pulsed on the third 
day with 1 uCi [SH]thymidine (New England Nuclear, Boston, MA), and harvested on the 
fourth day with an automated harvester (Mash II; Microbiological Associates, Bethesda, 
MD). 
Cell-mediated Lympholysis (CML).  Xenogeneic  CML  assays were  performed  using  a 
modification of techniques  described elsewhere (12-14).  Briefly, RPMI  1640  medium 
(Gibco Laboratories) was supplemented as above, except that 10% fetal calf serum (Gibco 
Laboratories) was used in place of normal mouse serum. Additionally, rat lymph node 
target cells were cultured in media with 10% normal rat serum in lieu of fetal calf serum. 
4  x  106 responders were co-cultured with 2  x  106 or 4  x  106 putative suppressors or 
control cells and 4 x  105 splenocyte stimulators (2,000 rad) in 2.5 ml of medium at 37°C 
for 5  d.  Mouse target blasts were stimulated with concanavalin A (Con A) (Miles  Yeda 
Research Products, Rehovot, Israel) for 2-3 d. Rat lymph node target cells were stimulated 
with phytohemagglutinin (PHA) (Gibco Laboratories) at a dilution of 1:400  for 3-4 d. 
After 5 d responders were harvested, counted, and resuspended at appropriate effector- 
to-target ratios with 1 x  104 5~Cr-labeled,  2-3-d Con A mouse splenocyte blasts or 3-4-d 
PHA rat lymph node blasts as targets. After 4.5 h, supernatants were harvested with the 
Titertek supernatant harvesting system and specific lysis was calculated as follows: specific 
lysis =  (experimental release -  spontaneous release)/(maximal HCI release -  machine 
background) x  100. Spontaneous release was <25% of maximum release unless otherwise 
indicated. 
IgG1  and  lgG2  Isotype Levels.  Levels  of  IgG1  and  IgG2  against  donor  lymphoid 
elements in sera were assessed by a direct binding assay on the FACS using purified FITC- 
GAMIgG1 and IgG2 reagents (provided by Dr. Howard Dickler, National Institutes of 
Health) as previously described (9). 
Plaque-forming Cell (PFC) Assays.  Sheep  red  blood  cell  (SRBC)  PFC  assays  were 
performed as previously described (15).  Briefly, animals were immunized intravenously 
with 0.2 cc of a  1% SRBC suspension on day 0. Partial splenectomies were performed on 
day  5,  splenic  lymphoid cells  were  harvested  as  resuspended  in  Hanks' balanced  salt 
solution with phenol red (M.A. Bioproducts, Walkersville, MD), and the standard plaque- 
forming assay was performed in triplicate at 1:10,  1:100, and 1:1,000 spleen cell equiva- 
lents to ensure the optimal number of plaques per slide. Values are reported as plaques 
per 106 spleen cells. All experiments reported were read blind. 
Results 
Survival  of Mice  Reconstituted  with Fully Xenogeneic  or Mixed Xenogeneic Bone 
Marrow Inocula.  Because we were interested in reconstituting mice with xeno- ILDSTAD  ET  AL.  1823 
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FIGURE  1.  Survival of fully and mixed xenogeneically  reconstituted  mice as calculated  by 
the  life-table  method.  All  bone  marrow  inocula  were  T  cell  depleted  with  RaMB  plus 
complement.  Fully xenogeneic: O,  2.0 X  107, rat (n =  24); O, 4.0 X  107 rat (n =  6); O,  8.0 x 
107 rat (n =  4). Mixed xenogeneic: A, 5  x  l0 s B10 +  4.0 x  107 rat (n =  14). 
geneic bone marrow  in an  attempt  to induce specific tolerance to subsequent 
xenografts,  we first attempted  fully xenogeneic marrow  transplantation  (F344 
rat ~  B 10). However, this approach was unsuccessful because survival of fully 
xenogeneically reconstituted animals was extremely poor, leading ultimately to 
death in all but one animal (Fig.  1). In contrast, B 10 recipient mice reconstituted 
with a mixture of syngeneic and xenogeneic F344 rat bone marrow cells showed 
a  long-term  survival similar to B10 animals  reconstituted with syngeneic bone 
marrow.  Survival  was  100%  at  00  d  and  86%  at  100  d  (Fig.  1).  The  mixed 
reconstituted  animals  all  appeared  healthy,  showing  none  of the  wasting  and 
debilitation exhibited in control animals reconstituted simultaneously with iden- 
tically treated rat bone marrow cells alone. All unreconstituted control animals 
died within 2 wk of irradiation. 
Titration of Syngeneic and Xenogeneic Bone Marrow Cells Required for Reconstitu- 
tion.  Titrations were performed to determine the optimal number of syngeneic 
and xenogeneic T  cell-depleted bone marrow cells required  to achieve repro- 
ducible reconstitution and tolerance. Although  1 x  106 syngeneic bone marrow 
cells was sufficient for survival in  80%  of animals,  a  dose of 5  x  106 cells was 
chosen since at this dose reconstitution  was observed in  100%  of animals  (data 
not shown). 
Optimal numbers of xenogeneic bone marrow cells required for induction of 
hyporeactivity was determined  by skin xenograft survival in  mixed xenogenei- 
cally reconstituted animals (Fig.  2).  Mixed reconstitution  of animals with  1.0 x 
107 T  Cell-depleted F344 rat bone marrow cells or less led to prompt rejection 
of skin xenografts in  100% of animals,  while animals reconstituted with greater 
than  this number of cells exhibited prolongation  of skin xenografts to varying 
degrees.  In  all  animals,  the  grafts  eventually  underwent  a  chronic  form  of 
rejection with  ultimate  disappearance  of the grafts in  most animals.  Although 
mixed reconstitution  with  2.0  x  107 T  cell-depleted  F344 bone marrow  cells 
led to specific skin  xenograft  prolongation  in  the majority of the animals,  the 
onset of chronic rejection occurred more rapidly and was more severe than  in 1824  HYPOREACTIVITY  TO  XENOGRAFTS  IN  MIXED  XENOGENEIC  MICE 
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FIGURE 2.  Dose-response effect ofreconstitution with T cell-depleted F344 rat bone marrow 
on skin xenograft survival. Animals were reconstituted with 5 x  106 T  cell-depleted syngeneic 
(B 10) bone marrow cells plus varying numbers of T  cell-depleted F344 rat bone marrow cells. 
O,  1.0 x  107 RaMB F344 (5); O, 2.0 x  107 RaMB F344 (7);O, 4.0 ×  l0  T RaMB (12); 0, 
syngeneic (B10 ~  B10) (5). 
mice  reconstituted  with  greater  numbers  of rat  bone  marrow  cells  (Fig.  2). 
Reconstitution  with  4.0,  6.0,  or  8.0  x  107  identically  treated  F344  rat  bone 
marrow cells resulted in prolongation of F344 xenografts with identical appear- 
ance (data not shown).  All additional  experiments  reported  in this study were 
performed with  5  x  106  syngeneic (B10) and  4.0  X  107  xenogeneic,  F344,  or 
WF T  cell-depleted bone marrow cells. 
Typing of Mixed Xenogeneically Reconstituted Mice.  Typing of the mixed xeno- 
geneically reconstituted animals by trypan blue exclusion microcytotoxicity assay 
revealed low numbers, if any, of detectable rat lymphoid elements in peripheral 
blood. Because the sensitivity of this assay is inadequate for accurate determina- 
tion of such low percentages of lymphoid cells, further analysis of the animals 
was pursued by flow microfluorometry (FMF) using splenic lymphoid cells and 
MLR  typing  in  which  chimeric  cells were  used  as  stimulators  of normal  B10 
responding cells. 
Analyses performed by FMF (FACS II) revealed that  0.5%  of F344 rat cells 
could  be detected when  mixed  with  B10  splenocytes and  stained  with  mouse 
anti-rat  sera.  There  was  no  cross-reactivity  of the  anti-H-2 b monoclonal  and 
mouse anti-rat  sera used in staining on the inappropriate  species. A  fully xeno- 
geneic chimera examined at 30 d post-reconstitution revealed 75% rat cells and 
40% H-2b-bearing cells present in splenic tissue (Fig.  3), which indicates that rat 
antigen could be detected in chimeric animals.  Under these staining conditions, 
rat cells were detectable at very low levels in only 20%  (5/25) of mixed xeno- 
geneically reconstituted animals tested from 6 to 16 wk post-reconstitution.  Fig. 
3 illustrates one representative animal with a low level of rat cells detectable. Rat 
cells were not detectable in thymus, bone marrow, peripheral blood, and lymph 
node examined in similar fashion (data not shown) despite the persistence of an 
F344 skin graft for >50 d. ILDSTAD  ET  AL.  1825 
FUlly XENO  MIXED XENO 
C 
I  I  Mo~,~  s,,,,  1.33 
,u  o.~ 
o 
0  | 
--,  ,  ,  ,, 
4 
(J 
2 
,=., 
m  1 
0 
4 
3 
]~  aH-2~  Monocior~al  Am/body  2 
, 
i  0 
LOG  B FLUORESCENCE INTENSITY 
aH-~ Monodona Annlmav 
I 
LOG  m FLUORESCENCE INTENSITY 
FZGURE 3.  FACS analysis of fully (a and b) and mixed (c and d) xenogeneically reconstituted 
animals,  b  Cells were stained with a monoclonal anti-H-2  antibody or mouse anti-rat sera, both 
demonstrated to have no cross-reactivity on inappropriate species cell type. 
TABLE  I 
Typing of Xenogeneically Reconstituted Animals by MLR 
Stimulation 
Responder*  Stimulator  cpm* +  SEM  indexS 
Chimera A  Chimera  1,095 +  246 
Chimera  B 10  1,183 _  425 
Normal B10  B10  1,009 __. 27 
Normal BI0  Chimera  2,694 +  251  2.7 
Chimera B  Chimera  1,584 +  202 
Chimera  BI0  1,397 _+ 94 
Normal B10  B10  2,886 __+ 920 
Normal BI0  Chimera  2,806 ___ 295  1.0 
Chimera C  Chimera  1,381  _  42 
Chimera  BI0  947 -4- 128 
Normal B10  B10  2,886 _  920 
Normal B10  Chimera  2,825 +  1,065  1.0 
* Analysis of spleens from three chimeras by MLR in attempt  to detect 
donor-type F344 cells. 
* Counts per minute of [3H]thymidine incorporation. 
0 Stimulation index compares ratio of normal B10 anti-chimera response 
to that of normal B10 anti-B10. 
Further  evaluation  of  mixed  xenogeneically  reconstituted  animals  was  per- 
formed  by  MLR  typing  in  which  normal  B10  responding  cells were  stimulated 
by  irradiated  chimeric  cells.  One  representative  experiment  performed  with 
spleen  cells  from  three  chimeras  is  shown  in  Table  I.  Most  animals  failed  to 1826  HYPOREACTIV1TY  TO  XENOGRAFTS  IN  MIXED  XENOGENEIC  MICE 
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FIGURE 4.  Skin xenograft survival in mixed xenogeneically reconstituted mice as calculated 
by the life-table method. Animals and skin grafts: O, mixed xenogeneic, F344 (26); O, mixed 
xenogeneic, B10.D2 (17); 0, mixed xenogeneic, B10 (5); 1"7, syngeneic, F344 (10); I, syngeneic, 
B10.D2 (5); A, normal BI0, F344 (10). 
stimulate a  proliferative response  in  normal  B10  responding cells.  However, 
some animals, such as chimera 1, did produce a  response, which indicates the 
possible persistence of xenogeneic elements. 
Specific Hyporeactivity  to Donor-Type Skin Grafts.  Mixed xenogeneically recon- 
stituted animals demonstrated reproducible specific hyporeactivity to donor-type 
full-thickness tail skin grafts (MST =  80 d) (Fig: 4). However, rejection of third- 
party aliografts (Fig. 4) and xenografts (Table II) followed a time course similar 
to that of syngeneically reconstituted animals (Fig. 4) and nonirradiated controls. 
The skin grafts varied in appearance and texture from soft to indurated, often 
with an appearance of prolonged chronic rejection. In the majority, the onset of 
the appearance of chronic rejection was from 20  to  90  d.  However, in some 
animals, the grafts remained soft and uninflammed for up to 120 d. 
To evaluate the degree of specificity of hyporeactivity to rat skin grafts, mice 
reconstituted with T  cell-depleted syngeneic (B10) plus either T  cell-depleted 
F344  or  WF  bone  marrow  were  grafted  with  both  F344  and  WF  tail  skin 
simultaneously. All skin grafts were read blind for the first 33  d.  Grafts were 
considered rejected when no  viable  residual could be detected.  As  shown in 
Table II, it was clear that hyporeactivity to donor-type skin was specific, since 
with few exceptions mice reconstituted with F344 bone marrow retained F344 
skin grafts but specifically rejected WF skin grafts with a time course similar to 
syngeneically (B 10 ~  B 10) reconstituted animals. Conversely, mice reconstituted 
with B 10 plus WF bone marrow were hyporeactive to WF skin but rejected F344 
rat  tail  skin  grafts  with  a  time  course  similar  to  syngeneically reconstituted 
animals. 
Serologic Reactivity and Attempts to Detect Enhancement.  Sera obtained sequen- 
tially following skin grafting of mixed xenogeneically reconstituted animals were 
tested  on  F344  rat  spleen  target  cells  by  complement-mediated cytotoxicity. 
Table  III  shows the  cytotoxic titers  and  maximum percentage  lysis  of F344 
target cells by sera from five representative animals. Included are data from one ILDSTAD  ET  AL. 
TABLE  II 
Skin Graft Specificity in Mixed Xenogenically Reconstituted Animals 
Animal  Reconstitution  number 
Skin graft survival (days) 
F344  MST  WF  MST 
Syngeneic 
Mixed xenogeneic 
(B10 +  WF ---* B10) 
Mixed xenogeneic 
(B10 +  F344 ---* B10) 
15  10 
1  9  9 
2  19  16 
3  15  15 
4  18  10 
5  9  9 
14  >53 
1  11  >53 
2  14  >53 
3  16  16 
4  9  9 
5  17  >53 
>53  15 
1  19  >53 
2  >53  13 
3  >53  15 
4  >53  15 
5  >53  17 
6  45  14 
7  >53  13 
8  >53  13 
9  >53  31 
The  majority  of  mixed,  xenogeneically  reconstituted  mice  specifically 
rejected third-party rat. The two exceptions to this in which third-party 
rat was prolonged were probably due to a degree of immunoincompetence 
in these animals. 
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TABLE  III 
Mixed Xenogeneic Chimeras: Cytotoxic Titer and Maximum Percent Kill of Sera Before and 
After Skin Grafting* 
Skin graft status  Animal  Prebleed* 
Days after skin grafting 
13  '22  36  45 
Rejected day  16  Chimera A  1:128 (65)  1:32 (66)  I:16 (66)  1:16 (72)  1:32 (71) 
Intact >120 d  Chimera B  1:32 (26)  1:8 (5)  1:2 (11)  1:8 (15)  <1:2 
Intact >120 d  Chimera C  1:8 (36)  1:8 (6)  1:2 (23)  <1:2  <1:2 
Rejected day 105  Chimera D  1:512 (51)  <1:2  <1:2  <1:2  1:2 (10) 
Rejected day 134  Chimera E  1:8 (18)  <1:2  <1:2 (6)  1:2 (17)  <1:2 
NA  Normal B101  <1:2  <1:2  <1:2  <1:2  <1:2 
* Represented as titer (maximum  percent kill) on  F344  spleen  target cells.  All are corrected for 
percent complement kill. 
Prebleed refers to post-reconstitution but pre-skin grafting. 
i Mean +  SD of maximum percent kill for normal BI0 serum =  4 +  2.35. 1828  HYPOREACTIVITY  TO  XENOGRAFTS  IN  MIXED  XENOGENEIC  MICE 
TABLE  IV 
Measurement of IgG l and IgG2 Level Specific  for F344 Lymphoid Cells by FMF* 
Sera 
IgG 1  IgG2 
Prebleed  Day 39 after  skin graft  A  Prebleed  Day 39 after  skin graft  A 
Normal mouse 
1170 
mouse anti-rat) 
Chimera 
Chimera 
Chimera 
Chimera 
Chimera 
Chimera 
25  24  24  24 
224  251  1,440  1,352 
60  55  -5  115  28  -8 
75  31  -44  87  27  -6 
24  30  6  26  27  1 
25  34  9  26  27  1 
100  28  -72  140  28  -16 
97  67  -30  272  111  -8 
* Values are represented as total fluorescence units normalized to an arbitrary amplification value 
(GAIN  16). F344 rat splenocytes were stained with sequentially collected sera. Controls included 
normal mouse serum and a mouse anti-rat sera. All chimeric sera were from animals whose F344 
rat grafts were intact for >39 d. 
animal,  chimera A, which rejected its F344 graft with a more rapid time course 
than most of the other animals. That animal demonstrated a relatively high titer 
and  maximum  percent  kill,  while the other animals  exhibited a  lower level of 
lysis similar to that for normal serum, while their skin grafts remained intact. 
Because serologic enhancement could be one possible mechanism responsible 
for the prolonged acceptance of the F344 skin grafts, we examined the sera of 
experimental  animals  with  grafts  still  intact  for  enhancing  antibody.  Because 
IgG1  and  IgG2  have  been  demonstrated  to  be  most  commonly  involved  in 
enhancement  (16),  we directed our attention  to analysis of levels of these two 
isotypes. Analysis of the sera from bleeds taken after reconstitution but before 
skin grafting and from day 50 after skin grafting revealed no increase in levels 
of gamma  1 or gamma  2 antibodies directed at  F344 lymphoid cells by direct 
binding assay on the FACS using purified FITC-GAMIgG1  and IgG2 reagents. 
In fact, suppression of IgG1 and IgG2 levels was noted in some animals following 
skin grafting (Table IV). 
In addition,  an attempt was made to passively transfer such hyporeactivity to 
normal B 10 animals.  Serum from animals with rat skin grafts intact from 30 to 
90 d was transferred (0.5 cc intravenously per normal B 10) 4 h before placement 
of F344 rat and B10.D2 skin grafts. Control animals were unmanipulated.  The 
rat and  allogeneic  skin  grafts were rejected with  identical  time  courses in  the 
control and experimental animals (data not shown). 
Specific  Tolerance  to Donor-Type  Lymphoid  Elements as Evidenced by MLR.  As 
seen  in  a  representative  mixed  lymphocyte culture  (Table  V),  no response  of 
chimeras to either host or donor-type stimulator cells was observed. Although 
the  mixed  xenogeneically reconstituted  animals  were somewhat suppressed  in 
their  overall  responses, their responses to third  party stimulators were present 
and specific. If one compares the ratios of response of the experimental animals 
to  WF or  B10.BR with  that  to  F344,  it can  be seen  that  the ratios are  much ILDSTAD  ET  AL.  1829 
TABLE  V 
Host Hyporeactivity and Third-Party Reactivity of Mixed Xenogeneically Reconstituted Animals 
(BIO + F344 Rat ---* BIO) in One-Way MLR* 
Animal  Anti-B 10 
[~H]Thymidine incorporation (cpm 4- SEM) 
Anti-F344  Anti-WF  Anti-B 10.BR 
Normal B10  2,886 4- 920  31, 152 ±  2013  38,134 +  4236  81,697 +  8403 
Normal F344  135,734 _  4108  4,710 +  309  97,816 ±  4267  144,925 ±  7607 
Chimera 1  1,397 ±  94  1,575 ±  297  8,581  4- 260  17,105 4- 977 
Chimera 2  947 4- 128  1,645 ±  293  7,619 ±  1385  9,519 ±  537 
* Mean 4- SEM of triplicate cultures in 1  : 1 responder-to-stimulator ratio. 
TABLE  VI 
Search for Putative Suppressors: MLR 
Responders  Actual values 
(4 x  105)  Additions  Anti-F344  Anti-B I 0.BR 
Normal B 10 
Normal B 10 
0  7,238 +  495  2,438 4- 1216 
2 ×  105 B10  12,470 _+ 1066  5,720 4- 2075 
2 ×  105 chimera 1  10,678 +  577  9,586 --- 2188 
2 ×  105 chimera 2  11,443 ___ 832  10,366 4- 1602 
0  6,429 -+ 795  4,168 _  1897 
4×  105B10  11,861  4-267  12,077±6166 
4 ×  105 chimera 1  11,699 +  507  26,590 4- 735 
4 ×  105 chimera 2  11,869 --- 482  25,353 4- 5693 
0  1,278 + 422  15,693 +  1512 
0  2,204 --- 165  21,004 4- 783 
Stimulation index* 
Chimera 1 
Chimera 2 
Additions  Anti-F344  Anti-B10.BR 
Normal B 10  2 x  105 chimera 1  1.5  2.9 
2 x  105 chimera 2  1.6  4.2 
2 x  105normal BI0  1.71  2.3 
4 ×  105 chimera 1  1.8  6.4 
4 ×  105 chimera 2  1.8  6.1 
4 X 105 normal B10  1.84  2.9 
* Compared  with  normal  B10  plus  2  or  4  X  105  normal  B10  anti-rat 
responclers. 
greater  than  that of normal  B 10 to the same stimulators,  which indicates specific 
tolerance  to donor-type  antigens. 
The  response  of normal  control  B 10 lymphocytes  against  F344  rat splenocytes 
in co-culture  with chimeric  cells has revealed  no evidence  for suppression  (Table 
VI).  Furthermore,  titration  of increasing  numbers  of co-cultured  chimeric  cells 
up  to  1.6  x  106  cells with  4  x  10 ~ normal  B10  responding  cells again  failed to 
reveal evidence  for suppression  of the B10 anti-F344  response  (data not shown). 
In  addition,  no  suppression  was  seen  in  the  reverse  direction  when  F344  rat 1830  HYPOREACTIVITY  TO  XENOGRAFTS  IN  MIXED  XENOGENEIC  MICE 
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FIGURE  5.  Specific  CTL  lysis  of mCr-labeled  target cells in one-way CML  to host, donor, 
and third party targets. Spontaneous release was <25% unless otherwise indicated. 
lymphocyte responding cells were co-cultured with unirradiated  chimeric splen- 
ocytes and C57BL/10Sn stimulators (data not shown). 
Specific Tolerance to Donor-Type Lymphoid Elements as Evidenced by CML.  Cells 
from mixed xenogeneically reconstituted animals were examined in an in vitro 
CML sensitization.  In one-way CML, responding cells were cultured with F344, 
B10, or third party murine or rat stimulators. Such attempts to sensitize (B10 + 
F344 ~  B10) spleen cells did not lead to cytotoxicity for either  host (B10) or 
donor (F344)-type Con A- or PHA-stimulated blasts, but did lead to effective 
lysis of third-party mouse (B 10.BR) and rat (WF) target cells (Fig. 5). This specific 
hyporeactivity persisted even after the onset of chronic  rejection and  eventual 
rejection of F344 skin grafts.  Syngeneically reconstituted animals tested simul- 
taneously  demonstrated  an  anti-F344  and  anti-third-party  response  at  levels 
similar to normal  B10 control responding cells. To detect suppression, normal 
B 10 responder cells were co-cultured with unirradiated  spleen cells from mixed 
xenogeneically resconstituted animals and F344 stimulators or third-party stim- 
ulators.  In  these  experiments,  co-culture  of chimeric  cells  with  normal  B10 
responder cells did not diminish  the anti-F344 response or the anti-third-party 
response, and thus provided no evidence for specific or nonspecific suppression 
(Fig. 6). 
Immunocompetence  as  Assessed  by  PFC  Responses.  In  an  attempt  to  further 
assess the in vivo immunocompetence of the mixed xenogeneically reconstituted 
animals, animals were subjected to intravenous immunization with SRBC suspen- 
sions and their ability to form PFC responses was quantitated.  The responses of 
the mixed xenogeneically reconstituted mice were found to be immunocompe- 
tent and similar to syngeneically (B10 --~ B10) reconstituted mice in B cell and ILDSTAD  ET  AL.  1831 
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FIGURE 6.  In an attempt to detect suppression, normal B 10 responding cells were co-cultured 
with  spleen  cells  from  mixed  xenogeneically  reconstituted  mice  and  F344  or  third-party 
stimulators in CML. One representative co-culture experiment is presented. Target cells are 
5~Cr-PHA F344 lymph node blasts. 
TABLE  VII 
In Vivo SRBC PFC Response 
Number  Plaques per 10  6 
Reconstitution  of ani-  P* 
mals  spleen cells* 
Syngeneic (B10 --.', B10)  9  62 (1.4)  -- 
Mixed xenogeneic (B10 +  5  38 (2.1)  <0.89 
F344 ----> B10) 
Fully allogeneic  0 (B 10. D2  8  13.7 (2)  <0.08 
B10) 
* Data  are  presented  as  geometric  means (standard error) of triplicate 
cultures read blind. 
|  Unable to evaluate fully xenogeneically reconstituted mice due to poor 
survivals. Therefore, fully allogeneic chimeras were chosen as the most 
appropriate controls available. 
* Significance  of  difference  between  the  two  experimental  groups  as 
compared  with syngeneically reconstituted animals by  two-tailed Stu- 
dent's t test. 
helper T cell interactions as assessed by their PFC responses. Fully xenogeneically 
reconstituted animals  did  not  survive  long  enough  for  evaluation,  and  fully 
ailogeneic chimeras were therefore chosen as  the  most  appropriate  available 
controls. As seen in Table VII, the majority of fully allogeneic chimeras (B 10.D2 
B 10) responded less well than did mixed xenogeneically reconstituted animals. 
Discussion 
Animal  models  for  fully  xenogeneic  chimeras  have  been  less  extensively 
investigated than those for allogeneic chimeras. This is in part due to the poor 
survival of such animals, presumably secondary to graft vs. host disease (17) and 
probable  immunoincompetence due  to  a  failure of appropriate  immune cell 
interactions in the reconstituted host similar to that described in fully allogeneic 
chimeras (18, 19). In our experience, the absence of wasting disease and excellent 
survivals  in  the  mixed  xenogeneically reconstituted  animals  was  in  striking 
contrast to those animals reconstituted with identically treated T  cell-depleted 
F344 bone marrow cells alone. It is difficult to assess  whether the death of the 
fully xenogeneically reconstituted animals was due to graft vs.  host disease or 
immunoincompetence. One can only conclude that  their survival is  poor but 1832  HYPOREACTIVITY  TO  XENOGRAFTS  IN  MIXED  XENOGENEIC  MICE 
prolonged over that of radiation controls if the animals are reconstituted with 
>2.0  X  10 7 Y cell-depleted F344 rat bone marrow cells. 
It is apparent from our data that the persistence of a high level of donor-type 
lymphoid cells is not a requirement for prolonged in vivo and in vitro hyporeac- 
tivity  to  donor-type  elements.  In  this  aspect,  the  mixed  xenogeneic  model 
resembles neonatal tolerance as first described by Billingham et al. (1), in which 
only very small numbers of donor-type cells have been found (20).  In fact, the 
percentage of rat cells detectable in peripheral lymphoid tissue was not a reliable 
prognosticator for the duration of skin xenograft prolongation or for the severity 
and  temporal  relationship  of the  chronic  rejection  reaction  that  eventually 
appeared in the skin grafts. The hyporeactivity to F344 rat antigens was mani- 
fested in varying degrees, depending upon the assay used. Although all mixed 
xenogeneically reconstituted animals  manifested specific prolongation  of skin 
xenograft survival,  most  grafts eventually underwent a  chronic rejection and 
were slowly rejected. In contrast,  in  vitro specific hyporeactivity to F344 lym- 
phocytes as assessed by MLR and CML was permanent and persisted even after 
the loss of F344 skin grafts following the prolonged chronic rejection. 
Enhancement by serum factors has been proposed as one mechanism contrib- 
uting to tolerance (16,  21). Voisin (21) reported no significant change in levels 
of IgG1  and  IgA  from pre-skin  grafting to  post-skin  grafting in  a  neonatal 
murine chimera system, although both of these levels were elevated in compari- 
son with normal control animals.  In our system, the levels of IgG1  and IgG2 
anti-rat antibody detectable in mixed xenogeneically reconstituted animals de- 
creased or remained unchanged in animals retaining their rat tail skin grafts. 
However, before skin grafting, all animals had a  degree of cytotoxic antibody 
directed against  F344  splenic  target  cells after bone  marrow grafting.  In  all 
animals that retained their xenografts for a prolonged period, the cytotoxic titer 
and maximum percentage lysis of donor-type target cells decreased or remained 
unchanged.  In contrast,  the  titer and maximum lysis  by serum from the one 
animal that rejected its skin graft rapidly remained elevated. These data could 
be suggestive of a possible humoral factor contributing to the specific hyporeac- 
tivity observed in vivo and in vitro in mixed xenogeneicaily reconstituted animals, 
although attempts to demonstrate enhancement with serum from hyporeactive 
animals were unsuccessful. Serum antibody could also represent a lack of toler- 
ance at the humoral level to donor-type xenogeneic lymphoid elements. In either 
case,  specific  hyporeactivity to  skin  xenografts  and  to  donor-type  lymphoid 
antigens in vitro appear in this model to occur in the presence of specific antibody 
production to F344 lymphoid cells. 
In search of putative active suppression, we performed mixing experiments in 
which chimeric lymphocytes were co-cultured with normal B10 or normal F344 
responding cells and B10, F344, or third-party stimulators in mixed lymphocyte 
culture. We chose mixed reconstituted animals with skin grafts still  intact with 
the presumption that the strong antigenic stimulus of an intact skin graft might 
expand  a  possible  suppressor  cell  population.  However,  neither  specific  nor 
nonspecific  suppression  of the  proliferative  reaction  in  MLR  and  cytotoxic 
lymphocyte reaction in CML could be demonstrated in numerous experiments. ILDSTAD ET  AL.  1833 
In addition,  no suppression of the F344 rat anti-B10  MLR response was noted 
in co-culture experiments. 
Although small percentages of donor-type cells have been identified in various 
lymphoid  compartments  of some  of the  mixed  xenogeneically  reconstituted 
animals,  many animals  have  had  no donor-type  cells detectable.  However, all 
animals have demonstrated prolongation of donor-type skin graft survival beyond 
that of syngeneically reconstituted controls.  Because skin is strongly antigeneic 
and the survival of skin grafts is frequently more difficult to prolong than most 
other  solid  organs  (22),  it  seems  likely  that  animals  manifesting  this  level  of 
hyporeactivity would be highly tolerant to xenografts of kidney, heart, or other 
vascularized  organs.  Studies  are  currently  in  progress  involving  heterotopic 
caridac xenograft transplantation  in such animals to assess this possibility. 
This new approach may provide a  model for investigation of mechanisms of 
self-recognition  and  antigen  processing  in  addition  to  that  of transplantation 
tolerance.  While clinical applications of mixed xenogeneic bone marrow recon- 
stitution  would  be  premature,  the  approach  may  offer  advantages  for  bone 
marrow  and  cadaver  donor  organ  transplantation.  Single  high-dose  radiation 
and immediate mixed reconstitution coincident with solid organ transplantation 
could,  for example,  afford  immediate  use of donor  organs  with  potential  for 
prolonged  acceptance  of the  donor  allograft  or  xenograft  in  the  absence  of 
prolonged nonspecific chemical immunosuppressive agents.  Attempts to extend 
these studies to a large animal model are in progress. 
Summary 
Mixed xenogeneically reconstituted mice (F344 rat + C57BL/10Sn ~  C57BL/ 
10Sn),  which specifically retain  F344 tail skin xenografts,  were studied for the 
specificity of such hyporeactivity and for in vitro reactivity and immunocompe- 
tence.  Survival of mixed reconstituted animals was excellent, without evidence 
for graft vs. host disease. Donor-type tail skin grafts were specifically prolonged 
(mean survival time =  80 d) in comparison with normal controls and syngeneically 
reconstituted animals.  In vitro,  such animals  manifested specific hyporeactivity 
by mixed  lymphocyte reaction  and  cell-mediated  lympholysis to  F344 rat  and 
B10  cells,  with  normal  response  to  third-party  rat  (Wistar-Furth)  and  mouse 
(B10.BR).  Examination  of lymphoid  tissues  with  a  fluorescence-activated  cell 
sorter  revealed  low  levels,  if any,  of donor-type  cells detectable.  This  system 
offers a model for investigation of xenogeneic transplantation  tolerance. 
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